Pfizer's Monthly Weight Loss Shot Shows Promising 12.3% Body Weight Reduction in Mid-Stage Trial
Pfizer releases Phase 2 data showing its monthly GLP-1 injection produced 12.3% weight loss at 28 weeks, positioning the company to compete with Eli Lilly and Novo Nordisk.